Group Life COVID-19 Mortality Survey - Updated through December 2022
NOTE: A more recent version of this survey, using data through June 2023, is available. View the updated survey.
Authors:
Patrick Hurley, FSA, MAAA
Mike Krohn, FSA, CERA, MAAA
Tony LaSala, FSA, MAAA
Rick Leavitt, ASA, MAAA
Cynthia S. MacDonald, FSA, MAAA, SOA
Patrick Nolan, FSA, MAAA, SOA
Steve Rulis, FSA, MAAA
Matthew Sawyer, FSA, MAAA
Description
The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through December 2022, as compared to prior period baseline mortality results. This new report is an update to the survey report released in November 2022, which contained data through June 2022.
The Society of Actuaries Research Institute’s May 2023 report and its predecessor reports regarding U.S. Group Life COVID-19 mortality explore the impact of COVID-19 on the group life insurance sector and do not address or consider vaccine status. The research does not validate any claims made that suggest a causal relationship between COVID-19 vaccines and mortality. Any claims implying such a relationship are a misrepresentation of the data presented in the report and are not reflective of the SOA Research Institute's views.
Materials
Group Life COVID-19 Mortality Survey
Questions or Comments?
Give us your feedback! Take a short survey on this report. Take Survey
If you have comments or questions, please send an email to research@soa.org.